“Advancements in non-invasive cancer diagnosis and therapy: The promise of telomerase inhibitors and telomere length analysis"-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

“Advancements in non-invasive cancer diagnosis and therapy: The promise of telomerase inhibitors and telomere length analysis"

Published:2024-06 Issue: Volume:10 Page:100545
ISSN:2772-9060
Container-title:Oral Oncology Reports
language:en
Short-container-title:Oral Oncology Reports

Author:

Shanmugam Geetha^ORCID

Publisher

Elsevier BV

Reference5 articles.

1. Telomere length changes in cancer: insights on carcinogenesis and potential for non-invasive diagnostic strategies;Holesova;Genes,2023

2. Telomeres and telomerase in oncogenesis;Trybek;Oncol Lett,2020

3. Telomerase in cancer: function, regulation, and clinical translation;Robinson;Cancers,2022

4. Association of telomere length with risk of disease and mortality;Schneider;JAMA Intern Med,2022

5. Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA);Ali;Cancer Cell Int,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP